ClinicalTrials.govpublic full text
The Efficacy and Safety of Neoadjuvant Therapy With Iparomlimab and Tuvonralimab in Locally Advanced MSI-H/dMMR Colorectal Cancer: An Prospective, Single-Arm Study (Neo-IT)
dmmr/msi-h-type rectal adenocarcinoma
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 454019
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.